Pharmacomodulations around the 4-oxo-1,4-dihydroquinoline-3-carboxamides, a class of potent CB2-selective cannabinoid receptor ligands: consequences in receptor affinity and functionality.

Source:http://linkedlifedata.com/resource/pubmed/id/17915849

J. Med. Chem. 2007 Nov 1 50 22 5471-84

Download in:

View as

General Info

PMID
17915849